Sirtex Medical Release: SIR-Spheres® microspheres as Effective and Safe in the Elderly as they are in Younger Patients With Colorectal Liver Metastases According to Data Released at American Society of Clinical Oncology Annual Meeting
5/30/2013 10:44:55 AM
More...
|
Sirtex Medical Release: Recruitment in World's Largest Interventional Oncology Study Completed
4/15/2013 9:53:46 AM
More...
|
Sirtex Medical Release: Interim Report – Half-Year Ended 31 December 2012
2/14/2013 6:37:17 AM
More...
|
Large U.S. Multi-Center Study Supports the Safety and Efficacy of Sirtex Medical’s SIR-Spheres® microspheres in Treating Colorectal Liver Metastases
1/24/2013 9:38:07 AM
More...
|
Sirtex Medical Deal Elevated With Liver Cancer Therapy: Real M&A
9/17/2012 7:41:40 AM
More...
|
Sirtex Medical Announces Record U.S. Earnings of $59 Million for Fiscal Year 2012
9/10/2012 9:45:02 AM
More...
|
Sirtex Medical Reports 2012 Full Year Financial Results
8/30/2012 9:39:04 AM
More...
|
Sirtex Medical Release: Large U.S. Multi-Center Study Confirms Safety and Efficacy of SIR-Spheres® microspheres in More Than 600 Patients with Unresectable Liver Metastases
6/4/2012 10:51:16 AM
More...
|
Sirtex Medical Posts Record Result With Continued Sales Growth
8/25/2011 10:07:00 AM
More...
|
Society Of Interventional Radiology Welcomes Corporate Gift From Sirtex Medical
8/16/2011 11:33:21 AM
More...
|
|